BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Prognosis
17 results:

  • 1. Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
    Zhao Y; Li D; Zhuang J; Li Z; Xia Q; Li Z; Yu J; Wang J; Zhang Y; Li K; Xu S; Li S; Ma P; Cao Y; Liu C; Xu C; Liu Z; Wei J; Zhang C; Qiao L; Gao X; Hou Z; Liu C; Zheng R; Wang D; Liu Y
    Clin Transl Med; 2024 May; 14(5):e1674. PubMed ID: 38685486
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
    Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
    Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
    Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
    Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
    Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
    Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles.
    Mattiolo P; Scarpa A; Luchini C
    Hum Pathol; 2023 Feb; 132():169-175. PubMed ID: 35714834
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological characteristics, survival outcomes, and genetic alterations of younger patients with gastric cancer: Results from the China National cancer Center and cBioPortal datasets.
    Niu P; Huang H; Zhao L; Wang T; Zhang X; Wang W; Zhang Y; Guo C; Zhao D; Chen Y
    Cancer Med; 2022 Aug; 11(16):3057-3073. PubMed ID: 35486034
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clonal Architectures Predict Clinical Outcome in gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity.
    Ren C; Wu C; Wang N; Lian C; Yang C
    Cell Transplant; 2021; 30():963689721989606. PubMed ID: 33900127
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. KMT2D promotes proliferation of gastric cancer cells: evidence from ctDNA sequencing.
    Li Q; Wu R; Wu F; Chen Q
    J Clin Lab Anal; 2021 Apr; 35(4):e23721. PubMed ID: 33793001
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Circ_SMAD4 promotes gastric carcinogenesis by activating wnt/β-catenin pathway.
    Wang L; Li B; Yi X; Xiao X; Zheng Q; Ma L
    Cell Prolif; 2021 Mar; 54(3):e12981. PubMed ID: 33458917
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nuclear MYH9-induced ctnnb1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
    Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
    Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
    [No Abstract]    [Full Text] [Related]  

  • 11. A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer.
    Bauer L; Hapfelmeier A; Blank S; Reiche M; Slotta-Huspenina J; Jesinghaus M; Novotny A; Schmidt T; Grosser B; Kohlruss M; Weichert W; Ott K; Keller G
    Ann Oncol; 2018 Jan; 29(1):127-132. PubMed ID: 29069277
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
    Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
    Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival.
    Bauer L; Langer R; Becker K; Hapfelmeier A; Ott K; Novotny A; Höfler H; Keller G
    PLoS One; 2012; 7(9):e44566. PubMed ID: 22970250
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic variation of ctnnb1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population.
    Wang S; Tian Y; Wu D; Zhu H; Luo D; Gong W; Zhou Y; Zhou J; Zhang Z
    Mutagenesis; 2012 Nov; 27(6):623-30. PubMed ID: 22848100
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular pathology of gastric carcinoma.
    Jang BG; Kim WH
    Pathobiology; 2011; 78(6):302-10. PubMed ID: 22104201
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Role of intraoperative assessment of lymph node metastasis and serosal invasion in patients with gastric cancer.
    Korenaga D; Okuyama T; Orita H; Anai H; Baba H; Maehara Y; Sugimachi K
    J Surg Oncol; 1994 Apr; 55(4):250-4. PubMed ID: 8159007
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.